Monitoring - read more


AMS  with its own permanently employed Clinical Research Associates across Europe and its partner CROs, globally, achieves extraordinarily good results in many aspects. This has been confirmed repeatedly by our clients.

AMS  CRAs have a broad range of indication experience with a strong focus in oncology and immunology (among others). Specialized teams operate with specific processes in early development clinical trials or late stage projects, respectively.

AMS  over the last decade repeatedly was the 1st to introduce new monitoring techniques and benefits today from having sound experience in using processes, such as Remote Monitoring, Centralized Monitoring and Risk-based-Monitoring.

AMS  operates a fully validated and easy to use EDC-system with extraordinarily good user acceptance at site level. Additionally, AMS  provides the most modern BYOD ePRO technologies* which have opened new possibilities in data collection, directly derived from patients.

*the fully validated AMS  BYOD-type Patient Reported Outcome solution (AMS -ePRO;) will help to save money and time, e.g. with Patient Diaries and Quality of Life Questionnaires. It significantly reduces the administrative burden in clinical trials.


Contact us:


• 2011 – AMS AMNOG Services pioneer • 2013 – AMS-Investigator SELF-TRAINING PORTAL • 2013 – “BEST CRO” by one of ther world’s Top 5 Pharma companies’ CRO Evaluation for AMS – Clinical Operations Services • 2014 – AMS performs Medical App Studies including eCRF-data integration • 2015 – AMS Medical Science is awarded “Provider of the Year, worldwide” the world’s Top 10 Pharma companies • 2015 – AMS develops an E-feasibility tool • 2015 – Innovative Tool for Patient Reported Outcomes: AMS-ePRO (BYOD-type PRO solution) is developed • 2016 – AMS – Regulatory Affairs is nominated on the short-list for TOPRA Award for Regulatory Excellence